News

pharmaphorum2d
Industry alarm as FDA's CBER head Peter Marks resigns
Dr Peter Marks, who has been director of the FDA's Centre for Biologics Evaluation and Research (CBER) since 2016. The abrupt departure of Peter Marks as the director of the FDA's Centre for ...
PBS21d
Breakthrough gene editing treatment helps child born with rare disorder
Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. Let's turn now ...
pharmaphorum4d
JPM: Four ways FDA is seeking to buoy gene therapy
Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, speaks at the Informa Biotech Showcase during JP Morgan week. One month ago, the FDA approved two gene therapies ...
PBS22d
Gene editing treatment helps child born with rare disorder
Geoff Bennett discussed the treatment and its potential with Dr. Peter Marks. He oversaw gene therapy treatment and vaccine safety and approval for the FDA before he left in March. PBS News Hour ...
FiercePharma29d
FDA misses another approval decision target date, this time for GSK's Nucala in COPD
“The FDA is actively reviewing our submission for ... though all signs point to it being Peter Marks, M.D., Ph.D., who exited the CBER in late March after allegedly butting heads with RFK ...
The Washington Post23d
FDA to issue new vaccine approval guidance amid questions over coronavirus shots
The FDA is a massive agency charged with regulating ... Prasad, a vocal critic of the agency, replaced Peter Marks, whom the Trump administration forced out in late March. Lauren Weber and Lena ...
KXAN27d
Vinay Prasad, a critic of drug industry and COVID-19 measures, to lead FDA vaccine program
Prasad replaces Dr. Peter Marks, FDA’s longtime vaccine chief who resigned in March after clashing with Health Secretary Robert F. Kennedy Jr. over concerns about the safety of vaccinations.
FierceBiotech22d
Martin Makary outlines AI plans and the broader vision for his term as FDA commissioner
The FDA is a great brand,” Makary said ... after its previous chief, Peter Marks, M.D., Ph.D., was forced out of his position last month—plans to meet with industry and CBER staff in ...
OPB28d
Former OHSU oncologist Vinay Prasad tapped by RFK Jr. to head FDA vaccine division
At the FDA, Prasad replaces Dr. Peter Marks, who resigned in March after saying Health and Human Services Secretary Robert F. Kennedy Jr. “wishes subservient confirmation of his misinformation ...
Upheaval at FDA pushes some biotech firms to move early trials out of US
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...
Precision Medicine Online13h
RFK Jr., FDA Officials Voice Support for Gene and Cell Therapies, Vow Flexibility in Rare Diseases
Trump administration health officials assured drugmakers and researchers at a roundtable hosted by the FDA that they want to ...